Clinical Trials Search

Title	Intervention	Sponsor	Status
Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation	Aspirin, Laboratory Biomarker Analysis, Questionnaire Administration, Placebo Administration	National Cancer Institute (NCI)	Active, not recruiting
Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger Healthy Participants	Laboratory Biomarker Analysis, Recombinant Human Papillomavirus Nonavalent Vaccine	National Cancer Institute (NCI)	Active, not recruiting
Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion	Laboratory Biomarker Analysis, Metformin Hydrochloride	National Cancer Institute (NCI)	Active, not recruiting
Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer	Exemestane, Laboratory Biomarker Analysis, Pharmacological Study, Quality-of-Life Assessment, Questionnaire Administration, Therapeutic Conventional Surgery, Placebo Administration	National Cancer Institute (NCI)	Active, not recruiting
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer	3-Dimensional Conformal Radiation Therapy, Cognitive Assessment, Intensity-Modulated Radiation Therapy, Laboratory Biomarker Analysis, Quality-of-Life Assessment	NRG Oncology	Active, not recruiting
Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer	Laboratory Biomarker Analysis, Nelipepimut-S Plus GM-CSF Vaccine, Sargramostim, Surgical Procedure	National Cancer Institute (NCI)	Active, not recruiting
Aging Mammary Stem Cells and Breast Cancer Prevention	Rapamycin	LuZhe Sun	Active, not recruiting
Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors	Carvedilol, Laboratory Biomarker Analysis, Pharmacological Study, Quality-of-Life Assessment, Questionnaire Administration, Pharmacogenomic Study, Placebo Administration	Children's Oncology Group	Active, not recruiting
DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection	Electroporation-Mediated Plasmid DNA Vaccine Therapy, HCV DNA Vaccine INO-8000, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Rocakinogene Sifuplasmid	National Cancer Institute (NCI)	Active, not recruiting
The National Myelodysplastic Syndromes (MDS) Study	Therapeutic	National Heart, Lung, and Blood Institute (NHLBI)	Recruiting

Search for Keywords

Major Program

Research Group

Status

Recruiting

Enrolling by invitation

Active, not recruiting

Not yet recruiting

Completed

Items per page

none

I was the first patient who Dr. Abraham enrolled on the NSABP B-31 clinical trial (chemo vs chemo + Trastuzumab in HER-2 positive breast cancer). I am grateful to him for presenting me with the opportunity to join the study 20 years ago in March 2001 and that I had the courage to participate, as I… show more

I was the first patient who Dr. Abraham enrolled on the NSABP B-31 clinical trial (chemo vs chemo + Trastuzumab in HER-2 positive breast cancer). I am grateful to him for presenting me with the opportunity to join the study 20 years ago in March 2001 and that I had the courage to participate, as I continue to do well to this day. This clinical trial ended up changing the landscape of treatment for future patients with breast cancer.

~Cyndi Mealey

Type(s) of Trial: Treatment

Trial Link(s): Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2